Exploring the structural activity relationship of the Osimertinib: A covalent inhibitor of double mutant EGFRL858R/T790M tyrosine kinase for the treatment of Non-Small Cell Lung Cancer (NSCLC)
| Autor: | Patil, Bhatu R., Bhadane, Kunal V., Ahmad, Iqrar, Agrawal, Yogesh J., Shimpi, Amit A., Dhangar, Mayur S., Patel, Harun M. |
|---|---|
| Zdroj: | In Bioorganic & Medicinal Chemistry 15 July 2024 109 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect